Radiotherapy Market by Product (LINAC, CyberKnife, Gamma Knife, Tomotherapy, Particle Therapy, Cyclotron), Procedure (External (IMRT, IGRT, 3D-CRT) Internal (LDR, HDR)), Application (Prostate, Breast, Lung), End User (Hospitals) - Global Industry Analysis, Share ,Growth ,Regional Outlook And Forecasts, 2021-2027

The global Radiotherapy market gathered revenue around USD 4.7 Billion in 2020 and market is set to grow USD 9.0 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 5.1% during the prediction period 2021 to 2027. Technological advancements in radiotherapy and the rising incidence of cancer are the major factors driving the growth of this market. Additionally, the growing adoption of radiotherapy procedures for cancer treatment, increasing use of particle therapy for cancer treatment, and the rising number of conferences and symposia focusing on the advancements in radiotherapy are some of the other major factors driving the growth of this market.

This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Radiotherapy market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Radiotherapy market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.

The rapid economic development and increasing healthcare expenditure in several emerging countries, such as China, India, Brazil, and Mexico, are expected to improve access to quality healthcare in these countries. This is considered a positive indicator for the radiotherapy market. The rising incidence of cancer in these countries is resulting in a growth in the demand for various radiotherapy devices and techniques. Moreover, governments across these countries are focused on providing modern and advanced healthcare services to larger proportions of their population, as well as the improvement of reimbursement coverage. 

COVID-19 Impact Assessment on Market Landscape

The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.

Radiotherapy market report empower readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.

Competitive Rivalry

Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.

Significant Market Participants Operational in the Radiotherapy Market are:

The dominant players in the global radiotherapy market are Varian Medical Systems, Inc. (US), Elekta (Sweden) Accuray Incorporated (US), Ion Beam Applications SA (Belgium), BD (US), Eckert & Ziegler (Germany), Hitachi Ltd. (Japan), ICAD, Inc. (US), IntraOp Medical, Inc. (US), IsoRay Medical, Inc. (US), Mevion Medical Systems, Inc. (US), Panacea Medical Technologies Pvt. Ltd. (India), P-cure Ltd. (Israel), ViewRay, Inc. (US), and ZEISS Group (Germany), among others.

Unravelling the Critical Segments

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:

Global Radiotherapy market, by Product

  • External Beam Radiotherapy
  • Electron-emitting High-energy Linear Accelerators
  • Conventional Linear Accelerators
  • Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators
    • Gamma Knife
    • CyberKnife
    • TomoTherapy
  • Conventional Cobalt-60 Teletherapy Units
  • Particle Therapy Systems
    • Cyclotrons
    • Synchrotrons
    • Synchrocyclotron
  • Internal Beam Radiotherapy/Brachytherapy
    • Seeds
    • Afterloaders
    • Applicators
    • IORT Systems
  • Systemic Radiotherapy
    • Iobenguane (I-131)
    • Samarium-153
    • Rhenium-186
    • Other Systemic Radiotherapy Products*

Global Radiotherapy market, by Application

  • External Beam Radiotherapy
    • Prostate Cancer
    • Breast Cancer
    • Lung Cancer
    • Head and Neck Cancer
    • Colorectal Cancer
    • Other Cancers
  • Internal Beam Radiotherapy/Brachytherapy
    • Prostate Cancer
    • Gynecological Cancer
    • Breast Cancer
    • Cervical Cancer
    • Penile Cancer
    • Other Cancers

Global Radiotherapy market, by Procedure

  • External Beam Radiotherapy
    • Image-guided Radiotherapy
    • Intensity-modulated Radiotherapy
    • Stereotactic Therapy
    • Particle Therapy
    • 3D Conformal Radiotherapy
  • Internal Beam Radiotherapy/Brachytherapy
    • High-dose-rate Brachytherapy
    • Low-dose-rate Brachytherapy
    • Pulsed-dose-rate Brachytherapy
  • Systemic Radiotherapy
  • Intravenous Radiotherapy
  • Oral Radiotherapy
  • Instillation Radiotherapy

Global Radiotherapy market, by End User

  • Hospitals
  • Independent Radiotherapy Centers

By Geography

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • United Kingdom
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Rest of Latin America

Middle East & Africa (MEA)

  • GCC
  • North Africa
  • South Africa
  • Rest of Middle East & Africa

Chapter 1.    Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.    Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.    Executive Summary

3.1.  Market Snapshot

Chapter 4.    Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.     Raw Material Procurement Analysis

4.3.2.     Sales and Distribution Channel Analysis

4.3.3.     Downstream Buyer Analysis

Chapter 5.    Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.     Market Drivers

5.1.2.     Market Restraints

5.1.3.     Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.     Bargaining power of suppliers

5.2.2.     Bargaining power of buyers

5.2.3.     Threat of substitute

5.2.4.     Threat of new entrants

5.2.5.     Degree of competition

Chapter 6.    Competitive Landscape

6.1.1.     Company Market Share/Positioning Analysis

6.1.2.     Key Strategies Adopted by Players

6.1.3.     Vendor Landscape

6.1.3.1.          List of Suppliers

6.1.3.2.          List of Buyers

Chapter 7.    Global Radiotherapy Market, By Product

7.1.  Radiotherapy  Market, by Product, 2021-2027

7.1.1.     External Beam Radiotherapy

7.1.1.1.          Market Revenue and Forecast (2016-2027)

7.1.2.     Electron-emitting High-energy Linear Accelerators

7.1.2.1.          Market Revenue and Forecast (2016-2027)

7.1.3.     Conventional Linear Accelerators

7.1.3.1.          Market Revenue and Forecast (2016-2027)

7.1.4.     Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators

7.1.4.1.          Market Revenue and Forecast (2016-2027)

7.1.5.     Conventional Cobalt-60 Teletherapy Units

7.1.5.1.          Market Revenue and Forecast (2016-2027)

7.1.6.     Particle Therapy Systems

7.1.6.1.          Market Revenue and Forecast (2016-2027)

7.1.7.     Internal Beam Radiotherapy/Brachytherapy

7.1.7.1.          Market Revenue and Forecast (2016-2027)

7.1.8.     Systemic Radiotherapy

7.1.8.1.          Market Revenue and Forecast (2016-2027)

Chapter 8.    Global Radiotherapy Market, By Application

8.1.  Radiotherapy  Market, by Application, 2021-2027

8.1.1.     External Beam Radiotherapy

8.1.1.1.          Market Revenue and Forecast (2016-2027)

8.1.2.     Internal Beam Radiotherapy/Brachytherapy

8.1.2.1.          Market Revenue and Forecast (2016-2027)

Chapter 9.    Global Radiotherapy Market, By Procedure

9.1.  Radiotherapy  Market, by Procedure, 2021-2027

9.1.1.     External Beam Radiotherapy

9.1.1.1.          Market Revenue and Forecast (2016-2027)

9.1.2.     Internal Beam Radiotherapy/Brachytherapy

9.1.2.1.          Market Revenue and Forecast (2016-2027)

9.1.3.     Systemic Radiotherapy

9.1.3.1.          Market Revenue and Forecast (2016-2027)

9.1.4.     Intravenous Radiotherapy

9.1.4.1.          Market Revenue and Forecast (2016-2027)

9.1.5.     Oral Radiotherapy

9.1.5.1.          Market Revenue and Forecast (2016-2027)

9.1.6.     Instillation Radiotherapy

9.1.6.1.          Market Revenue and Forecast (2016-2027)

Chapter 10.Global Radiotherapy Market, By End User

10.1.          Radiotherapy  Market, by End User, 2021-2027

10.1.1.  Hospitals

10.1.1.1.       Market Revenue and Forecast (2016-2027)

10.1.2.  Independent Radiotherapy Centers

10.1.2.1.       Market Revenue and Forecast (2016-2027)

Chapter 11.Global Radiotherapy  Market, Regional Estimates and Trend Forecast

11.1.          North America

11.1.1.  Market Revenue and Forecast, by Product (2016-2027)

11.1.2.  Market Revenue and Forecast, by Application (2016-2027)

11.1.3.  Market Revenue and Forecast, by Procedure (2016-2027)

11.1.4.  Market Revenue and Forecast, by End User (2016-2027)

11.1.5.  U.S.

11.1.5.1.       Market Revenue and Forecast, by Product (2016-2027)

11.1.5.2.       Market Revenue and Forecast, by Application (2016-2027)

11.1.5.3.       Market Revenue and Forecast, by Procedure (2016-2027)

11.1.5.4.       Market Revenue and Forecast, by End User (2016-2027)

11.1.6.  Rest of North America

11.1.6.1.       Market Revenue and Forecast, by Product (2016-2027)

11.1.6.2.       Market Revenue and Forecast, by Application (2016-2027)

11.1.6.3.       Market Revenue and Forecast, by Procedure (2016-2027)

11.1.6.4.       Market Revenue and Forecast, by End User (2016-2027)

11.2.          Europe

11.2.1.  Market Revenue and Forecast, by Product (2016-2027)

11.2.2.  Market Revenue and Forecast, by Application (2016-2027)

11.2.3.  Market Revenue and Forecast, by Procedure (2016-2027)

11.2.4.  Market Revenue and Forecast, by End User (2016-2027)

11.2.5.  UK

11.2.5.1.       Market Revenue and Forecast, by Product (2016-2027)

11.2.5.2.       Market Revenue and Forecast, by Application (2016-2027)

11.2.5.3.       Market Revenue and Forecast, by Procedure (2016-2027)

11.2.5.4.       Market Revenue and Forecast, by End User (2016-2027)

11.2.6.  Germany

11.2.6.1.       Market Revenue and Forecast, by Product(2016-2027)

11.2.6.2.       Market Revenue and Forecast, by Application (2016-2027)

11.2.6.3.       Market Revenue and Forecast, by Procedure (2016-2027)

11.2.6.4.       Market Revenue and Forecast, by End User (2016-2027)

11.2.7.  France

11.2.7.1.       Market Revenue and Forecast, by Product (2016-2027)

11.2.7.2.       Market Revenue and Forecast, by Application (2016-2027)

11.2.7.3.       Market Revenue and Forecast, by Procedure (2016-2027)

11.2.7.4.       Market Revenue and Forecast, by End User (2016-2027)

11.2.8.  Rest of Europe

11.2.8.1.       Market Revenue and Forecast, by Product (2016-2027)

11.2.8.2.       Market Revenue and Forecast, by Application (2016-2027)

11.2.8.3.       Market Revenue and Forecast, by Procedure (2016-2027)

11.2.8.4.       Market Revenue and Forecast, by End User (2016-2027)

11.3.          APAC

11.3.1.  Market Revenue and Forecast, by Product (2016-2027)

11.3.2.  Market Revenue and Forecast, by Application (2016-2027)

11.3.3.  Market Revenue and Forecast, by Procedure (2016-2027)

11.3.4.  Market Revenue and Forecast, by End User (2016-2027)

11.3.5.  India

11.3.5.1.       Market Revenue and Forecast, by Product (2016-2027)

11.3.5.2.       Market Revenue and Forecast, by Application (2016-2027)

11.3.5.3.       Market Revenue and Forecast, by Procedure (2016-2027)

11.3.5.4.       Market Revenue and Forecast, by End User (2016-2027)

11.3.6.  China

11.3.6.1.       Market Revenue and Forecast, by Product (2016-2027)

11.3.6.2.       Market Revenue and Forecast, by Application (2016-2027)

11.3.6.3.       Market Revenue and Forecast, by Procedure (2016-2027)

11.3.6.4.       Market Revenue and Forecast, by End User (2016-2027)

11.3.7.  Japan

11.3.7.1.       Market Revenue and Forecast, by Product (2016-2027)

11.3.7.2.       Market Revenue and Forecast, by Application (2016-2027)

11.3.7.3.       Market Revenue and Forecast, by Procedure (2016-2027)

11.3.7.4.       Market Revenue and Forecast, by End User (2016-2027)

11.3.8.  Rest of APAC

11.3.8.1.       Market Revenue and Forecast, by Product (2016-2027)

11.3.8.2.       Market Revenue and Forecast, by Application (2016-2027)

11.3.8.3.       Market Revenue and Forecast, by Procedure (2016-2027)

11.3.8.4.       Market Revenue and Forecast, by End User (2016-2027)

11.4.          MEA

11.4.1.  Market Revenue and Forecast, by Product (2016-2027)

11.4.2.  Market Revenue and Forecast, by Application (2016-2027)

11.4.3.  Market Revenue and Forecast, by Procedure (2016-2027)

11.4.4.  Market Revenue and Forecast, by End User (2016-2027)

11.4.5.  GCC

11.4.5.1.       Market Revenue and Forecast, by Product (2016-2027)

11.4.5.2.       Market Revenue and Forecast, by Application (2016-2027)

11.4.5.3.       Market Revenue and Forecast, by Procedure (2016-2027)

11.4.5.4.       Market Revenue and Forecast, by End User (2016-2027)

11.4.6.  North Africa

11.4.6.1.       Market Revenue and Forecast, by Product (2016-2027)

11.4.6.2.       Market Revenue and Forecast, by Application (2016-2027)

11.4.6.3.       Market Revenue and Forecast, by Procedure (2016-2027)

11.4.6.4.       Market Revenue and Forecast, by End User (2016-2027)

11.4.7.  South Africa

11.4.7.1.       Market Revenue and Forecast, by Product (2016-2027)

11.4.7.2.       Market Revenue and Forecast, by Application (2016-2027)

11.4.7.3.       Market Revenue and Forecast, by Procedure (2016-2027)

11.4.7.4.       Market Revenue and Forecast, by End User (2016-2027)

11.4.8.  Rest of MEA

11.4.8.1.       Market Revenue and Forecast, by Product (2016-2027)

11.4.8.2.       Market Revenue and Forecast, by Application (2016-2027)

11.4.8.3.       Market Revenue and Forecast, by Procedure (2016-2027)

11.4.8.4.       Market Revenue and Forecast, by End User (2016-2027)

11.5.          Latin America

11.5.1.  Market Revenue and Forecast, by Product (2016-2027)

11.5.2.  Market Revenue and Forecast, by Application (2016-2027)

11.5.3.  Market Revenue and Forecast, by Procedure (2016-2027)

11.5.4.  Market Revenue and Forecast, by End User (2016-2027)

11.5.5.  Brazil

11.5.5.1.       Market Revenue and Forecast, by Product (2016-2027)

11.5.5.2.       Market Revenue and Forecast, by Application (2016-2027)

11.5.5.3.       Market Revenue and Forecast, by Procedure (2016-2027)

11.5.5.4.       Market Revenue and Forecast, by End User (2016-2027)

11.5.6.  Rest of LATAM

11.5.6.1.       Market Revenue and Forecast, by Product (2016-2027)

11.5.6.2.       Market Revenue and Forecast, by Application (2016-2027)

11.5.6.3.       Market Revenue and Forecast, by Procedure (2016-2027)

11.5.6.4.       Market Revenue and Forecast, by End User (2016-2027)

Chapter 12.   Company Profiles

12.1.                 Varian Medical Systems, Inc. (US)

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.                 Elekta (Sweden)

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.                 Accuray Incorporated (US)

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.                 Ion Beam Applications SA (Belgium)

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.                 BD (US)

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.                 Eckert & Ziegler (Germany)

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.                 Hitachi Ltd. (Japan)

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.                 ICAD, Inc. (US)

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.                 IntraOp Medical, Inc. (US)

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.              IsoRay Medical, Inc. (US)

12.10.1.                   Company Overview

12.10.2.                   Product Offerings

12.10.3.                   Financial Performance

12.10.4.                   Recent Initiatives

12.11.              Mevion Medical Systems, Inc. (US)

12.11.1.                   Company Overview

12.11.2.                   Product Offerings

12.11.3.                   Financial Performance

12.11.4.                   Recent Initiatives

12.12.              Panacea Medical Technologies Pvt. Ltd. (India)

12.12.1.                   Company Overview

12.12.2.                   Product Offerings

12.12.3.                   Financial Performance

12.12.4.                   Recent Initiatives

12.13.              P-cure Ltd. (Israel)

12.13.1.                   Company Overview

12.13.2.                   Product Offerings

12.13.3.                   Financial Performance

12.13.4.                   Recent Initiatives

12.14.              ViewRay, Inc. (US)

12.14.1.                   Company Overview

12.14.2.                   Product Offerings

12.14.3.                   Financial Performance

12.14.4.                   Recent Initiatives

12.15.              ZEISS Group (Germany)

12.15.1.                   Company Overview

12.15.2.                   Product Offerings

12.15.3.                   Financial Performance

12.15.4.                   Recent Initiatives

Chapter 13.   Research Methodology

13.1.                 Primary Research

13.2.                 Secondary Research

13.3.                 Assumptions

Chapter 14.   Appendix

14.1.                 About Us

14.2.                 Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-img Cross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers
Ask To Expert